	US 11,938,250 B2
	Article coatings including oligomerized polyphenol layer and biological methods of use
David E. Babcock, Brooklyn Park, MN (US); Sean Lundquist, Chaska, MN (US); Gary Opperman, St. Louis Park, MN (US); Adriyn Torguson, Maple Grove, MN (US); and Tim Jentz, Minnetonka, MN (US)
Assigned to Surmodics, Inc., Eden Prairie, MN (US)
Filed by Surmodics, Inc., Eden Praire, MN (US)
Filed on Feb. 11, 2019, as Appl. No. 16/272,808.
Application 16/272,808 is a continuation of application No. 15/502,345, granted, now 10,201,637, previously published as PCT/US2015/044002, filed on Aug. 6, 2015.
Claims priority of provisional application 62/035,173, filed on Aug. 8, 2014.
Prior Publication US 2019/0275209 A1, Sep. 12, 2019
Int. Cl. A61L 29/08 (2006.01); A61K 31/7024 (2006.01); A61L 15/44 (2006.01); A61L 27/34 (2006.01); A61L 27/54 (2006.01); A61L 29/06 (2006.01); A61L 29/16 (2006.01); A61L 31/10 (2006.01); A61L 31/16 (2006.01); G01N 33/543 (2006.01)

CPC A61L 29/085 (2013.01) [A61K 31/7024 (2013.01); A61L 15/44 (2013.01); A61L 27/34 (2013.01); A61L 27/54 (2013.01); A61L 29/06 (2013.01); A61L 29/16 (2013.01); A61L 31/10 (2013.01); A61L 31/16 (2013.01); G01N 33/54393 (2013.01); A61L 2300/216 (2013.01); A61L 2300/418 (2013.01); A61L 2300/42 (2013.01); A61L 2400/04 (2013.01); A61L 2400/18 (2013.01); A61L 2420/02 (2013.01); A61L 2420/08 (2013.01)]

17 Claims

1. A medical device comprising a water-insoluble hemostatic coating comprising an immobilized oligomerized polyphenol, the device configured so the immobilized oligomerized polyphenol comes in contact with a body fluid, and wherein the hemostatic coating has a thickness of less than 100 nm.